Parametric Portfolio Associates’s Ocular Therapeutix OCUL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$139K	Buy	28,068 +8,056	+40%	+$44.7K	﹤0.01%	3511
2021 Q4	$139K	Buy	20,012 +4,212	+27%	+$32.7K	﹤0.01%	3501
2021 Q3	$158K	Sell	15,800 -2,541	-14%	-$28.5K	﹤0.01%	3477
2021 Q2	$260K	Buy	18,341 +2,376	+15%	+$36.1K	﹤0.01%	3311
2021 Q1	$262K	Sell	15,965 -82,126	-84%	-$1.58M	﹤0.01%	3769
2020 Q4	$2.03M	Buy	98,091 +84,789	+637%	+$1.26M	﹤0.01%	2640
2020 Q3	$101K	Sell	13,302 -5,495	-29%	-$45.6K	﹤0.01%	3794
2020 Q2	$157K	Buy	18,797 +6,034	+47%	+$40K	﹤0.01%	3692
2020 Q1	$63K	Buy	12,763 +1,229	+11%	+$6.07K	﹤0.01%	3804
2019 Q4	$46K	Sell	11,534 -2,983	-21%	-$10.4K	﹤0.01%	3926
2019 Q3	$44K	Buy	14,517 +2,259	+18%	+$10.1K	﹤0.01%	3903
2019 Q2	$54K	Sell	12,258 -9,891	-45%	-$36.6K	﹤0.01%	3904
2019 Q1	$88K	Buy	22,149 +994	+5%	+$4K	﹤0.01%	3832
2018 Q4	$84K	Sell	21,155 -32,613	-61%	-$180K	﹤0.01%	3802
2018 Q3	$370K	Sell	53,768 -3,057	-5%	-$19.2K	﹤0.01%	3549
2018 Q2	$384K	Sell	56,825 -4,649	-8%	-$31.9K	﹤0.01%	3455
2018 Q1	$400K	Buy	61,474 +24,576	+67%	+$138K	﹤0.01%	3448
2017 Q4	$164K	Sell	36,898 -13,321	-27%	-$68K	﹤0.01%	3783
2017 Q3	$310K	Sell	50,219 -10,300	-17%	-$66.3K	﹤0.01%	3662
2017 Q2	$561K	Buy	60,519 +29,937	+98%	+$290K	﹤0.01%	3299
2017 Q1	$284K	Buy	30,582 +401	+1%	+$3.34K	﹤0.01%	3453
2016 Q4	$253K	Buy	+30,181	New	+$234K	﹤0.01%	3505

Other funds holding OCUL